Europe Acute Pancreatitis Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 – Regional Analysis – by Offerings (Medications, Diagnosis, and Others), Causes (Gallstones, Alcoholism, Genetic Disorders, Infection, and Others), and End User (Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers, and Others)

No. of Pages: 113    |    Report Code: BMIRE00029223    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Acute Pancreatitis Market

1.           Introduction

1.1       The Insight Partners Research Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

2.2       Europe Acute Pancreatitis Market, by Country (US$ Million)

3.           Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.           Europe Acute Pancreatitis Market Landscape

4.1       Overview

5.           Europe Acute Pancreatitis Market - Key Industry Dynamics

5.1       Key Market Drivers

5.1.1         Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis

5.1.2         Rising Incidence of Diabetes Following Acute Pancreatitis

5.2       Key Market Restraints

5.2.1         Side Effects of Pancreatitis and Pancreatic Cancer Treatments

5.3       Key Market Opportunities

5.3.1         Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis

5.4       Future Trends

5.4.1         Advancements in Specific Acute Pancreatitis Treatments

5.5       Impact Analysis:

6.           Acute Pancreatitis Market - Europe Market Analysis

6.1       Europe Acute Pancreatitis Market Revenue (US$ Mn), 2022 – 2030

7.           Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 – by Offerings

7.1       Overview

7.2       Europe Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)

7.3       Medications

7.3.1         Overview

7.3.2         Medications: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

7.3.2.1           Europe Acute Pancreatitis Market, by Medications, 2020–2030 (US$ Million)

7.4       Diagnosis

7.4.1         Overview

7.4.2         Diagnosis: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

7.4.2.1           Europe Acute Pancreatitis Market, by Diagnosis, 2020–2030 (US$ Million)

7.5       Others

7.5.1         Overview

7.5.2         Others: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

8.           Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 – by Causes

8.1       Overview

8.2       Europe Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)

8.3       Gallstones

8.3.1         Overview

8.3.2         Gallstones: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

8.4       Alcoholism

8.4.1         Overview

8.4.2         Alcoholism: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

8.5       Genetic Disorders

8.5.1         Overview

8.5.2         Genetic Disorders: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

8.6       Infections

8.6.1         Overview

8.6.2         Infections: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

8.7       Others

8.7.1         Overview

8.7.2         Others: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

9.           Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 – by End User

9.1       Overview

9.2       Europe Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)

9.3       Hospitals

9.3.1         Overview

9.3.2         Hospitals: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

9.4       Diagnostic Laboratories

9.4.1         Overview

9.4.2         Diagnostic Laboratories: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

9.5       Ambulatory Surgical Centers

9.5.1         Overview

9.5.2         Ambulatory Surgical Centers: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

9.6       Others

9.6.1         Overview

9.6.2         Others: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

10.        Europe Acute Pancreatitis Market - Country Analysis

10.1     Overview

10.1.1.1         Europe Acute Pancreatitis Market, by Country

10.1.1.2         UK

10.1.1.2.1       Overview

10.1.1.2.2       UK: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.2.3       UK: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)

10.1.1.2.3.1        UK: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)

10.1.1.2.3.2        UK: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)

10.1.1.2.4       UK: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)

10.1.1.2.5       UK: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)

10.1.1.3         Germany

10.1.1.3.1       Overview

10.1.1.3.2       Germany: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.3.3       Germany: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)

10.1.1.3.3.1        Germany: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)

10.1.1.3.3.2        Germany: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)

10.1.1.3.4       Germany: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)

10.1.1.3.5       Germany: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)

10.1.1.4         France

10.1.1.4.1       Overview

10.1.1.4.2       France: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.4.3       France: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)

10.1.1.4.3.1        France: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)

10.1.1.4.3.2        France: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)

10.1.1.4.4       France: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)

10.1.1.4.5       France: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)

10.1.1.5         Italy

10.1.1.5.1       Overview

10.1.1.5.2       Italy: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.5.3       Italy: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)

10.1.1.5.3.1        Italy: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)

10.1.1.5.3.2        Italy: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)

10.1.1.5.4       Italy: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)

10.1.1.5.5       Italy: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)

10.1.1.6         Spain

10.1.1.6.1       Overview

10.1.1.6.2       Spain: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.6.3       Spain: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)

10.1.1.6.3.1        Spain: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)

10.1.1.6.3.2        Spain: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)

10.1.1.6.4       Spain: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)

10.1.1.6.5       Spain: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)

10.1.1.7         Nordic Region

10.1.1.7.1       Overview

10.1.1.7.2       Nordic Region: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.7.3       Nordic Region: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)

10.1.1.7.3.1        Nordic Region: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)

10.1.1.7.3.2        Nordic Region: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)

10.1.1.7.4       Nordic Region: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)

10.1.1.7.5       Nordic Region: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)

10.1.1.8         Netherlands

10.1.1.8.1       Overview

10.1.1.8.2       Netherlands: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.8.3       Netherlands: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)

10.1.1.8.3.1        Netherlands: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)

10.1.1.8.3.2        Netherlands: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)

10.1.1.8.4       Netherlands: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)

10.1.1.8.5       Netherlands: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)

10.1.1.9         Rest of Europe

10.1.1.9.1       Overview

10.1.1.9.2       Rest of Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.9.3       Rest of Europe: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)

10.1.1.9.3.1        Rest of Europe: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)

10.1.1.9.3.2        Rest of Europe: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)

10.1.1.9.4       Rest of Europe: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)

10.1.1.9.5       Rest of Europe: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)

11.        Europe Acute Pancreatitis Market–Industry Landscape

11.1     Overview

11.2     Growth Strategies in the Europe Acute Pancreatitis Market

11.3     Inorganic Growth Strategies

11.3.1       Overview

11.4     Organic Growth Strategies

11.4.1       Overview

12.        Company Profiles

12.1     Abbott Laboratories

12.1.1       Key Facts

12.1.2       Business Description

12.1.3       Products and Services

12.1.4       Financial Overview

12.1.5       SWOT Analysis

12.1.6       Key Developments

12.2     GE HealthCare Technologies Inc

12.2.1       Key Facts

12.2.2       Business Description

12.2.3       Products and Services

12.2.4       Financial Overview

12.2.5       SWOT Analysis

12.2.6       Key Developments

12.3     Samsung Healthcare

12.3.1       Key Facts

12.3.2       Business Description

12.3.3       Products and Services

12.3.4       Financial Overview

12.3.5       SWOT Analysis

12.3.6       Key Developments

12.4     Koninklijke Philips NV

12.4.1       Key Facts

12.4.2       Business Description

12.4.3       Products and Services

12.4.4       Financial Overview

12.4.5       SWOT Analysis

12.4.6       Key Developments

12.5     Baxter International Inc

12.5.1       Key Facts

12.5.2       Business Description

12.5.3       Products and Services

12.5.4       Financial Overview

12.5.5       SWOT Analysis

12.5.6       Key Developments

12.6     Dynavax Technologies Corp

12.6.1       Key Facts

12.6.2       Business Description

12.6.3       Products and Services

12.6.4       Financial Overview

12.6.5       SWOT Analysis

12.6.6       Key Developments

12.7     Actim Oy

12.7.1       Key Facts

12.7.2       Business Description

12.7.3       Products and Services

12.7.4       Financial Overview

12.7.5       SWOT Analysis

12.7.6       Key Developments

12.8     Medtronic Plc

12.8.1       Key Facts

12.8.2       Business Description

12.8.3       Products and Services

12.8.4       Financial Overview

12.8.5       SWOT Analysis

12.8.6       Key Developments

12.9     Boston Scientific Corp

12.9.1       Key Facts

12.9.2       Business Description

12.9.3       Products and Services

12.9.4       Financial Overview

12.9.5       SWOT Analysis

12.9.6       Key Developments

12.10  Fresenius Kabi AG

12.10.1    Key Facts

12.10.2    Business Description

12.10.3    Products and Services

12.10.4    Financial Overview

12.10.5    SWOT Analysis

12.10.6    Key Developments

13.        Appendix

13.1     About Us

13.2     Glossary of Terms

 

 

 

 

LIST OF TABLES

Table 1.              Europe Acute Pancreatitis Market Segmentation

Table 2.              Europe Acute Pancreatitis Market, by Medications – Revenue and Forecast to 2030 (US$ Million)

Table 3.              Europe Acute Pancreatitis Market, by Diagnosis – Revenue and Forecast to 2030 (US$ Million)

Table 4.              UK: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 5.              UK: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 6.              UK: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 7.              UK: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)

Table 8.              UK: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 9.              Germany: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 10.           Germany: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 11.           Germany: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 12.           Germany: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)

Table 13.           Germany: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 14.           France: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 15.           France: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 16.           France: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 17.           France: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)

Table 18.           France: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 19.           Italy: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 20.           Italy: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 21.           Italy: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 22.           Italy: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)

Table 23.           Italy: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 24.           Spain: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 25.           Spain: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 26.           Spain: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 27.           Spain: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)

Table 28.           Spain: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 29.           Nordic Region: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 30.           Nordic Region: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 31.           Nordic Region: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 32.           Nordic Region: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)

Table 33.           Nordic Region: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 34.           Netherlands: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 35.           Netherlands: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 36.           Netherlands: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 37.           Netherlands: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)

Table 38.           Netherlands: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 39.           Rest of Europe: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 40.           Rest of Europe: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 41.           Rest of Europe: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)

Table 42.           Rest of Europe: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)

Table 43.           Rest of Europe: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 44.           Recent Inorganic Growth Strategies in the Europe Acute Pancreatitis Market

Table 45.           Recent Organic Growth Strategies in the Europe Acute Pancreatitis Market

Table 46.           Glossary of Terms, Europe Acute Pancreatitis Market

 

 

LIST OF FIGURES

Figure 1.            Europe Acute Pancreatitis Market Segmentation, By Country

Figure 2.            Europe Acute Pancreatitis Market - Key Industry Dynamics

Figure 3.            Impact Analysis of Drivers and Restraints

Figure 4.            Europe Acute Pancreatitis Market Revenue (US$ Mn), 2022 – 2030

Figure 5.            Europe Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)

Figure 6.            Medications: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

Figure 7.            Diagnosis: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

Figure 8.            Others: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

Figure 9.            Europe Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)

Figure 10.          Gallstones: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

Figure 11.          Alcoholism: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12.          Genetic Disorders: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

Figure 13.          Infections: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

Figure 14.          Others: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

Figure 15.          Europe Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)

Figure 16.          Hospitals: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

Figure 17.          Diagnostic Laboratories: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

Figure 18.          Ambulatory Surgical Centers: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

Figure 19.          Others: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)

Figure 20.          Europe Acute Pancreatitis Market, by Key Country – Revenue, 2022 (US$ Million)

Figure 21.          Europe Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)

Figure 22.          UK: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

Figure 23.          Germany: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

Figure 24.          France: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

Figure 25.          Italy: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

Figure 26.          Spain: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

Figure 27.          Nordic Region: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

Figure 28.          Netherlands: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

Figure 29.          Rest of Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

Figure 30.          Growth Strategies in the Europe Acute Pancreatitis Market

The List of Companies - Europe Acute Pancreatitis Market

  1. Abbott Laboratories
  2. Actim Oy
  3. Baxter International Inc
  4. Boston Scientific Corp
  5. Dynavax Technologies Corp
  6. Fresenius Kabi AG
  7. GE HealthCare Technologies Inc
  8. Koninklijke Philips NV
  9. Medtronic Plc
  10. Samsung Healthcare